<DOC>
	<DOCNO>NCT02484534</DOCNO>
	<brief_summary>Cirrhotic patient patient high morbidity mortality , important determine prognosis patient . The importance increase patient wait liver transplant . The Model End-Stage Liver Disease ( MELD ) reliable measure mortality risk patient end-stage liver disease . It use disease severity index help prioritize allocation organ transplant . MELD use patient value serum bilirubin , serum creatinine , international normalize ratio prothrombin time ( INR ) predict survival . Blood test use today daily practice evaluate coagulation system ( PT , PTT ) check actually function system , examine level clot factor therefore verify side Anticoagulant equation side procoagulant . To examine coagulation system function test develop , One thrombin generation . The purpose trial determine whether thrombin generation test prognostic indicator patient cirrhosis .</brief_summary>
	<brief_title>Thrombin Generation Test Patient With Liver Cirrhosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Thrombin</mesh_term>
	<criteria>Cirrhosis patient MELD ( Model For EndStage Liver Disease ) 12 Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Coagulation Factor</keyword>
	<keyword>cirrhosis</keyword>
</DOC>